After adjusting possible confounders, including age, smoking, stage, and tumor size, EGFR mutation was one of the predictors for subsequent BM (HR = 1.89, 95% CI = 1.12~3.17, p = 0.017). This evidence concerns the gene EGFR and neoplasm.